Singular Genomics Systems (OMIC)
(Delayed Data from NSDQ)
$0.36 USD
0.00 (0.19%)
Updated May 31, 2024 04:00 PM ET
After-Market: $0.37 +0.01 (1.45%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OMIC 0.36 0.00(0.19%)
Will OMIC be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for OMIC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OMIC
Similar Genomics Systems (OMIC) Reports Q1 Loss, Lags Revenue Estimates
Similar Genomics Systems (OMIC) Reports Q4 Loss, Tops Revenue Estimates
OMIC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Similar Genomics Systems (OMIC) Could be Great Choice for a Bottom Fisher
Similar Genomics Systems (OMIC) Upgraded to Buy: Here's What You Should Know
3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1
Other News for OMIC
Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference
Lab Instrument Industry Update - New Commercial Entrants
Analysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE), Legend Biotech (LEGN) and Singular Genomics Systems (OMIC)
Singular Genomics Systems Inc (OMIC) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
Similar Genomics Systems: Q1 Earnings Snapshot